Recombinant human endostatin combined with chemotherapy for advanced squamous cell lung cancer: a meta-analysis
Abstract Background This paper aims to compare the efficacy and safety of recombinant human endostatin combined with chemotherapy in patients with squamous cell lung cancer (SqCLC). Methods We searched the Cochrane Library, PubMed, Embase, CNKI, Wanfang database, Metstr, VIP, and others and manually...
Main Authors: | Li Feng, Zhicong Wang, Li Jing, Zhiguo Zhou, Shuai Shi, Ruoying Deng, Yibing Liu, Qingju Meng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-021-02161-1 |
Similar Items
-
Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer
by: Biaoxue Rong, et al.
Published: (2012-08-01) -
Mechanism of Shenyi Capsule Concomitant with Endostar and Chemotherapy on the Growth and Apoptosis of MCF-7 Breast Cancer Cells
by: Mingwen Shao, et al.
Published: (2014-06-01) -
The Comparison of Clinical Effect of Rh-endostar on Retreated Non-Small Cell Lung Cancer and Colorectal Cancer
by: Xueqin YANG, et al.
Published: (2009-11-01) -
Endostar continuous versus intermittent intravenous infusion combined with chemotherapy for advanced NSCLC: a systematic review and meta-analysis including non-randomized studies
by: Bo Wang, et al.
Published: (2020-10-01) -
Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma
by: Rong-Sheng Qin, et al.
Published: (2018-10-01)